The comparative effectiveness of metformin and risperidone in a rat model of valproic acid-induced autism, Potential role for enhanced autophagy

RATIONALE: Risperidone is the first antipsychotic to be approved by Food and Drug Administration (FDA) for treating autism spectrum disorder (ASD). The potential efficacy of metformin in preventing and/or controlling ASD behavioral deficits was also recently reported. Suppression of hippocampus auto...

Descripción completa

Detalles Bibliográficos
Autores principales: Atia, Amany AA, Ashour, Rehab H, Zaki, Marwa MAF, Rahman, Karawan MA, Ramadan, Nehal M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172247/
https://www.ncbi.nlm.nih.gov/pubmed/37133558
http://dx.doi.org/10.1007/s00213-023-06371-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172247/
https://www.ncbi.nlm.nih.gov/pubmed/37133558
http://dx.doi.org/10.1007/s00213-023-06371-1

Ejemplares similares